Market Tracker

05/29 12:30pm ET

Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

4.01
Delayed Data
As of May 26
 -0.29 / -6.74%
Today’s Change
1.83
Today|||52-Week Range
10.40
+106.70%
Year-to-Date
No recent news for Pernix Therapeutics Holdings Inc.

Today’s Trading

Previous close4.30
Today’s open4.27
Day’s range3.94 - 4.33
Volume298,110
Average volume (3 months)656,993
Market cap$40.2M
Dividend yield--
Data as of 3:59pm ET, 05/26/2017

Growth & Valuation

Earnings growth (last year)+22.05%
Earnings growth (this year)+25.93%
Earnings growth (next 5 years)+13.60%
Revenue growth (last year)-19.90%
P/E ratioNM
Price/Sales0.11
Price/Book--

Competitors

 Today’s
change
Today’s
% change
MTEXMannatech Inc0.000.00%
NBYNovaBay Pharmaceutic...-0.05-1.82%
CBLICleveland Biolabs In...-0.09-2.36%
SCYXSCYNEXIS Inc+0.04+2.45%
Data as of 3:59pm ET, 05/26/2017

Financials

Next reporting dateAugust 11, 2017
EPS forecast (this quarter)-$4.40
Annual revenue (last year)$140.9M
Annual profit (last year)-$169.6M
Net profit margin-120.40%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
John A. Sedor
President, Chief Financial Officer &
Director
Graham G. Miao
Corporate headquarters
Morristown, New Jersey

Forecasts